BARD1 was postulated as a hereditary breast and ovarian cancer (HBOC) predisposing gene shortly after it was first described, due to its relationship with BRCA1 in terms of shared structural homology and functional association for the development of their tumor-suppressor roles1. This evidence concerns the gene BRCA1 and neoplasm.